{"id":"https://openalex.org/W2612397484","doi":"https://doi.org/10.1182/blood.v128.22.1505.1505","title":"Subcutaneous Low Dose Alemtuzumab: Role As a Salvage Therapy in Immune -Mediated Marrow Failure Conditions","display_name":"Subcutaneous Low Dose Alemtuzumab: Role As a Salvage Therapy in Immune -Mediated Marrow Failure Conditions","publication_year":2016,"publication_date":"2016-12-02","ids":{"openalex":"https://openalex.org/W2612397484","doi":"https://doi.org/10.1182/blood.v128.22.1505.1505","mag":"2612397484"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v128.22.1505.1505","doi":"https://doi.org/10.1182/blood.v128.22.1505.1505","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.1505.1505","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067600974","display_name":"Swapna Thota","orcid":"https://orcid.org/0000-0002-4216-1414","observed_orcids":["https://orcid.org/0000-0002-4216-1414"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Swapna Thota","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047181107","display_name":"Srinivasa Reddy Sanikommu","orcid":"https://orcid.org/0000-0002-9681-0483","observed_orcids":["https://orcid.org/0000-0002-9681-0483"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srinivasa Reddy Sanikommu","raw_affiliation_strings":["Department of Translational Hematology and Oncology, Cleveland Clinic Taussing Cancer Institute, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology, Cleveland Clinic Taussing Cancer Institute, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114429797","display_name":"Bhumika J. Patel","orcid":"https://orcid.org/0009-0008-4984-7751","observed_orcids":["https://orcid.org/0009-0008-4984-7751"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Bhumika Patel","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031507854","display_name":"Meena Sadaps","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Meena Sadaps","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112104644","display_name":"Cassandra M. Hirsch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Cassandra M. Hirsch","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038219766","display_name":"Michael J. Clemente","orcid":"https://orcid.org/0000-0003-4345-3934","observed_orcids":["https://orcid.org/0000-0003-4345-3934"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael J. Clemente","raw_affiliation_strings":["Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047791859","display_name":"Serena Marotta","orcid":"https://orcid.org/0000-0001-7708-6699","observed_orcids":["https://orcid.org/0000-0001-7708-6699"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Serena Marotta","raw_affiliation_strings":["Hematology, Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049668306","display_name":"Antonio Maria Risitano","orcid":"https://orcid.org/0000-0002-4744-5109","observed_orcids":["https://orcid.org/0000-0002-4744-5109"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Antonio M Risitano","raw_affiliation_strings":["Hematology, Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055740968","display_name":"Mikkael Aaron Sekeres","orcid":"https://orcid.org/0000-0003-2009-6524","observed_orcids":["https://orcid.org/0000-0003-2009-6524"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mikkael A. Sekeres","raw_affiliation_strings":["Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085974329","display_name":"Jaroslaw Pawel Maciejewski","orcid":"https://orcid.org/0000-0002-6837-4346","observed_orcids":["https://orcid.org/0000-0002-6837-4346"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaroslaw P Maciejewski","raw_affiliation_strings":["Taussig Cancer Institute / Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute / Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5031507854","https://openalex.org/A5038219766","https://openalex.org/A5047791859","https://openalex.org/A5067600974","https://openalex.org/A5112104644","https://openalex.org/A5114429797"],"corresponding_institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I71267560"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.2303,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.53225904,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"128","issue":"22","first_page":"1505","last_page":"1505"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12919","display_name":"Blood disorders and treatments","score":0.8852999806404114,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12919","display_name":"Blood disorders and treatments","score":0.8852999806404114,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13374","display_name":"Hematological disorders and diagnostics","score":0.06069999933242798,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.01119999960064888,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aplastic-anemia","display_name":"aplastic anemia","score":0.7799999713897705},{"id":"https://openalex.org/keywords/pure-red-cell-aplasia","display_name":"pure red cell aplasia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/idiopathic-neutropenia","display_name":"idiopathic neutropenia","score":0.9739999771118164},{"id":"https://openalex.org/keywords/large-granular-lymphocytic-leukemia","display_name":"large granular lymphocyte leukemia","score":0.9409999847412109},{"id":"https://openalex.org/keywords/bone-marrow-failure","display_name":"bone marrow failure","score":0.7960000038146973},{"id":"https://openalex.org/keywords/immune-mediated-cytopenia","display_name":"immune-mediated cytopenia","score":0.7770000100135803},{"id":"https://openalex.org/keywords/salvage-therapy","display_name":"salvage therapy","score":0.8259999752044678},{"id":"https://openalex.org/keywords/cd52-monoclonal-antibody","display_name":"CD52 monoclonal antibody","score":0.9490000009536743},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7020000219345093},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.6029999852180481},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.6909999847412109}],"concepts":[{"id":"https://openalex.org/C2779015954","wikidata":"https://www.wikidata.org/wiki/Q420164","display_name":"Alemtuzumab","level":3,"score":0.9314717054367065},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8944413661956787},{"id":"https://openalex.org/C2781440808","wikidata":"https://www.wikidata.org/wiki/Q846316","display_name":"Aplastic anemia","level":3,"score":0.6458297967910767},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.6354188323020935},{"id":"https://openalex.org/C2777422296","wikidata":"https://www.wikidata.org/wiki/Q751631","display_name":"Pure red cell aplasia","level":3,"score":0.5978178977966309},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5917612314224243},{"id":"https://openalex.org/C2780525284","wikidata":"https://www.wikidata.org/wiki/Q7882181","display_name":"Bone marrow failure","level":4,"score":0.5457664132118225},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5284019708633423},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.5171996355056763},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4834505021572113},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.47143808007240295},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.46253255009651184},{"id":"https://openalex.org/C2778384904","wikidata":"https://www.wikidata.org/wiki/Q21108353","display_name":"CD52","level":4,"score":0.4471934139728546},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.41103675961494446},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3625578284263611},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3077833652496338},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.2435380518436432},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v128.22.1505.1505","doi":"https://doi.org/10.1182/blood.v128.22.1505.1505","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.1505.1505","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2754587197","https://openalex.org/W2993808621","https://openalex.org/W2525690204","https://openalex.org/W2037713259","https://openalex.org/W2588680878","https://openalex.org/W2988108974","https://openalex.org/W2123969730","https://openalex.org/W2593212351","https://openalex.org/W2589107944","https://openalex.org/W2589587755"],"abstract_inverted_index":{"Abstract":[0],"Aplastic":[1],"anemia":[2],"(AA),":[3],"pure":[4,9],"red":[5],"cell":[6,11,19],"aplasia":[7,12],"(PRCA),":[8],"white":[10],"(PWCA),":[13],"idiopathic":[14,389],"neutropenia":[15],"(IN)":[16],"and":[17,53,68,79,167,234,240,411,485,492,508,539,559,584,599],"T":[18],"large":[20],"granular":[21],"lymphocytic":[22,50],"leukemia":[23,51],"(LGL)":[24],"are":[25],"bone":[26],"marrow":[27],"failure":[28],"(BMF)":[29],"conditions":[30,143],"unified":[31],"by":[32,189,527],"immune-mediated":[33],"pathogenesis":[34],"leading":[35],"to":[36,111,121,226,270,366,467,549,623,627,660],"cytopenias.":[37],"Intravenous":[38],"alemtuzumab,":[39,175],"a":[40,59,216,285,289,341,412,423,513,562,607,645,664],"CD52":[41],"monoclonal":[42],"antibody":[43],"approved":[44],"for":[45,55,196,238,264,518,649,667,673],"the":[46,95,118,125,130,310,367,379,436,454,578,587,596,602],"treatment":[47,104,222,447,464,618],"of":[48,64,98,132,170,184,247,291,294,343,354,391,414,425,432,438,442,453,531,534,537,543,564,577,586,595,601,676],"chronic":[49],"(CLL)":[52],"used":[54,75,257],"relapsed":[56,302,319,376],"AA,":[57,532,571],"has":[58],"response":[60,523,550],"rate":[61,524],"in":[62,76,81,261,276,329,451,457,551,575,591,637,655],"AA":[63,161,266,312,552],"37-58%.":[65],"However,":[66],"dosing":[67],"route":[69],"was":[70,249,256,402,444,448,525,553],"likely":[71],"based":[72],"on":[73],"those":[74],"CLL":[77],"regimens":[78],"resulted":[80],"significant":[82],"immunosuppressive":[83,629],"complications.":[84],"Here":[85],"we":[86,572],"summarize":[87],"our":[88],"experience":[89],"with":[90,113,141,160,220,268,325,336,351,395,419,422,429,477,505,581,631,651,663],"sc":[91,174,187,642],"alemtuzumab":[92,337,597,643],"given":[93,176],"at":[94,124,129,197,363],"maximum":[96],"dose":[97,183,205],"total":[99],"100":[100],"mg":[101,186,191],"as":[102,258,670,672],"etiologic":[103],"(either":[105],"salvage":[106,259],"therapy":[107,260,295],"or":[108,128,193,223,228,273,304,317,321,397],"preferred":[109],"therapy)":[110],"patients":[112,122,140,159,214,248,279,287,313,333,408,417,459,514,650,658],"various":[114],"BMF.":[115],"We":[116],"investigated":[117],"therapies":[119],"administered":[120],"seen":[123],"Cleveland":[126,262],"Clinic":[127],"University":[131],"Naples":[133,277],"(NCT00895739)":[134],"between":[135],"years":[136,251],"2002-2015.":[137],"Of":[138],"484":[139],"BMF":[142,307,652],"(Cleveland:":[144],"AA:":[145,152],"204,":[146],"LGL:":[147,154],"174,":[148],"PRCA:":[149,156],"56;":[150],"Naples:":[151],"24,":[153],"2,":[155],"14),":[157],"65":[158],"(N=22),":[162,164],"PRCA":[163,384,538,592],"LGL":[165,332,369,377],"(N=18)":[166,334],"3":[168,185,265,393],"cases":[169,267,385,542,579],"IN/PWCA":[171],"were":[172,280,315,338,348,387,499,620],"treated":[173,335,386,580],"according":[177],"2":[178,292,344],"distinct":[179],"schedules:":[180],"i.":[181],"initial":[182],"followed":[188],"10":[190],"once":[192],"twice":[194],"weekly":[195],"least":[198],"8":[199],"consecutive":[200],"weeks;":[201],"ii.":[202],"4-5":[203],"day":[204],"escalation":[206],"(3-10-30-30-30":[207],"mg)":[208],"regimen.":[209],"In":[210,570,639],"both":[211],"schedules,":[212],"some":[213],"received":[215,232],"much":[217],"longer":[218],"course":[219,465],"maintenance":[221],"occasional":[224],"boosts":[225],"prevent":[227],"treat":[229],"relapse.":[230],"Patients":[231],"bactrim":[233],"acyclovir":[235],"prophylaxis,":[236],"IVIG":[237],"hypoglobulinemia":[239],"underwent":[241],"CMV":[242,480],"monitoring.":[243],"The":[244,446,470,521,546],"median":[245,290,342,424,547,563,608],"age":[246],"57.5":[250],"(range:":[252,296,556,567],"31-84":[253],"years).":[254],"Alemtuzumab":[255],"(except":[263],"contraindication":[269],"anti-thymocyte":[271],"globulin":[272],"cyclosporine),":[274],"whereas":[275],"untreated":[278,300,407],"allowed":[281],"per":[282],"protocol.":[283],"As":[284],"result,":[286],"had":[288,298,318,340,375,381],"lines":[293],"0-6),":[297],"either":[299,388],"(35%),":[301],"(22%)":[303],"refractory":[305,322,382,420,519,626],"(43%)":[306],"condition.":[308],"Among":[309,435],"22":[311],"12":[314,554],"untreated,":[316],"(N=4),":[320],"disease":[323,528,604],"(N=6),":[324],"concomitant":[326],"PNH":[327],"clone":[328],"8/22":[330],"patients.":[331],"younger,":[339],"prior":[345,427],"therapies,":[346,428],"50%":[347],"STAT3":[349],"mutants,":[350],"comparable":[352],"degree":[353],"cytopenias":[355],"but":[356],"excess":[357],"splenomegaly":[358],"(60%":[359],"vs.":[360],"38%,":[361],"p=.012)":[362],"presentation,":[364],"compared":[365],"remainder":[368],"cohort.":[370],"Amongst":[371],"these":[372],"patients,":[373,455],"18%":[374],"while":[378],"rest":[380],"disease.":[383,589,679],"(N=18,":[390],"whom":[392],"associated":[394],"thymoma)":[396],"LGL-associated":[398],"(N=4);":[399],"this":[400],"group":[401,437],"very":[403],"heterogeneous,":[404],"including":[405],"9":[406],"(in":[409,512],"Naples)":[410],"subgroup":[413],"heavily":[415],"pretreated":[416,504],"(5":[418],"disease)":[421],"5":[426],"mean":[430],"hemoglobin":[431],"7.5":[433],"g/dL.":[434],"PWCA/IN,":[439],"one":[440],"case":[441],"PWCA":[443],"LGL-associated.":[445],"well":[449,671],"tolerated":[450],"92%":[452],"except":[456],"four":[458],"who":[460],"did":[461],"not":[462],"complete":[463],"due":[466,622],"adverse":[468,472],"events.":[469],"main":[471],"events":[473],"include":[474],"infectious":[475,668],"complications":[476],"7/65":[478],"developing":[479],"reactivation,":[481,484],"4/65":[482],"HSV":[483],"more":[486],"rarely":[487],"other":[488,506],"viral":[489],"reactivation":[490],"(VZV":[491],"HBV,":[493],"1/65":[494],"each).":[495],"Two":[496],"fatal":[497],"infections":[498],"recorded:":[500],"1":[501,509],"fungemia":[502],"(heavily":[503],"therapies)":[507],"JCV-related":[510],"PML":[511],"also":[515],"receiving":[516],"chemotherapy":[517],"thymoma).":[520],"overall":[522],"55%;":[526],"subtype":[529],"54%":[530],"44%":[533],"LGL,":[535],"59%":[536],"all":[540],"three":[541],"PWCA/IN":[544],"responded.":[545,605],"time":[548],"weeks":[555],"6-24":[557],"weeks),":[558],"responses":[560,574],"lasted":[561],"6":[565],"months":[566],"2-72":[568],"months).":[569],"observed":[573],"72%":[576],"almetuzumab":[582],"upfront":[583,598],"45%":[585],"relapsed/refractory":[588,603,656],"Similarly":[590],"cases,":[593],"77%":[594],"46%":[600],"With":[606],"follow":[609],"up":[610],">4":[611],"years,":[612],"no":[613],"late":[614],"treatment-related":[615],"complication":[616],"emerged;":[617],"failures":[619],"mostly":[621],"relapses":[624],"(sometimes":[625],"further":[628],"treatment),":[630],"clonal":[632],"evolution":[633],"around":[634],"15%":[635],"(mostly":[636],"non-responders).":[638],"summary,":[640],"low-dose":[641],"is":[644],"reasonable":[646],"alternative":[647],"option":[648],"conditions,":[653],"especially":[654],"cases;":[657],"need":[659],"be":[661],"monitored":[662],"heightened":[665],"vigilance":[666],"complications,":[669],"possible":[674],"recurrence":[675],"their":[677],"underlying":[678],"Disclosures":[680],"Risitano:":[681],"Alexion":[682],"Pharmaceuticals:":[683],"Other:":[684],"lecture":[685],"fees,":[686],"Research":[687,690,693,696],"Funding;":[688,691,694],"Alnylam:":[689],"Rapharma:":[692],"Novartis:":[695],"Funding.":[697]},"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2017-05-19T00:00:00"}